ing individuals. Conclusion: These differences in the characteristics of ESBL producers may represent different sources of colonization. Most LTC applicants harboured K. pneumoniae or E. coli that were probably hospital-acquired whereas the E. coli isolates of many healthy individuals showed similarities to environmental E. coli .
Introduction
Enterobacteriaceae that produce extended-spectrum beta-lactamases (ESBLs) have become a major problem worldwide, especially since the occurrence and spread of the bla CTX-M family. Many of these enzymes, in contrast to the bla TEM and bla SHV groups, are linked to epidemic clones [1] and some of them, e.g. the bla CTX-M-15 -producing Escherichia coli O25b:ST131 and Klebsiella pneumoniae ST11, ST15 and ST147 clonal complexes, have become pandemic both in the nosocomial and community settings as well as in long-term care (LTC) facilities [1] [2] [3] . The switch from K. pneumoniae to E. coli as the major ESBL producer species is also linked to the dissemination of bla CTX-M genes [4] .
The gastrointestinal tracts of humans and even animals are obviously a major source of ESBL producer spe-cies [5, 6] and also serve as a site for the horizontal spread of resistance genes [7] . The duration of asymptomatic carriage can be very long, up to several years in some cases [8] , and international travel contributes to even more efficient spreading [9] . Carriage rates, and therefore the risk of colonization, in travelers returning home are highest in Southeast Asia [6, 8] , as high as 69.3%. North Africa and the eastern Mediterranean are also associated with a higher carriage risk in travelers [9] .
Although a number of studies have been published on faecal carriage rates in different populations (both patients and asymptomatic individuals), colonization patterns have only started to be understood. Therefore, the aim of this study was to compare the prevalence of faecal carriage and the characteristics of ESBL producers among applicants for LTC and individuals screened for employment purposes.
Materials and Methods

Samples and Isolates
A total of 1,640 faecal samples from 2 groups of asymptomatic individuals not suffering from infection at the time of sampling were investigated between March 2009 and April 2010. Samples were collected and sent for screening for enteric pathogens from 1,109 individuals (300 males and 809 females with a median age of 34 years, range 15-68 years) being screened for employment eligibility purposes (e.g. jobs at hospitals, kindergartens and food-processing plants) and 531 individuals (218 males and 313 females with a median age of 75 years, range 0-100 years) who needed to be screened prior to admittance to LTC facilities. The vast majority of individuals were located in north-eastern Hungary from the EU regions of Northern Hungary and the Northern Great Plain.
The samples were directly inoculated onto eosin-methylene blue agar plates supplemented with 2 mg/l cefotaxime. All colonies with different morphology were further identified by means of biochemical tests; enterobacterial isolates were then processed further.
According to Clinical and Laboratory Standards Institute guidelines, antibiotic susceptibility testing was performed by the disc-diffusion method against imipenem, cefotaxime, ceftazidime, cefepime, ciprofloxacin, colistin, trimethoprim-sulfamethoxazole (co-trimoxazole), doxycycline, amikacin, gentamicin, tobramycin and tigecycline. All isolates showing a decreased susceptibility to at least 1 third-generation cephalosporin or to cefepime were tested for ESBL phenotype using the double-disc synergy test (Oxoid, Basingstoke, UK) and then re-identified using a MALDI Biotyper (Bruker, Bremen, Germany). Imipenem-resistant isolates were also tested using the Hodge test as specified in the Clinical and Laboratory Standards Institute guidelines.
In the case of isolates displaying an ESBL phenotype, DNA was extracted by heat treatment. PCR amplifications were carried out in a MyCycler PCR machine (BioRad, Hercules, Calif., USA). Species identification for K. pneumoniae and E. coli isolates was confirmed by species-specific PCRs [10, 11] .
Genetic Relatedness
The epidemiological relationship was analyzed by enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) with ERIC2 and ERIC1R primers (as described earlier [12] ) and pulsed-field gel electrophoresis (PFGE). Plugs were prepared as described earlier [13] , macrorestriction was performed using XbaI (Fermentas, Vilnius, Lithuania) in a CHEF DRIII machine (Bio-Rad) in 1% SeaKem Gold agarose (Lonza) at 14 ° C. Electrophoresis was performed at 6 V/cm, with a reorientation angle of 120°, and switch times were ramped between 2 and 64 s for 20 h for both species. Gels were stained with ethidium bromide and visualized under UV light. Banding patterns were analyzed with Fingerprinting II software (Bio-Rad). The threshold for probable unrelatedness was set at <85% similarity. The Simpson index of diversity (D) was calculated to assess diversity, as described earlier [14] .
Identification of ESBL Genes
The bla TEM , bla SHV , bla CTX-M genes were detected by PCR, as described previously [15] [16] [17] ; bla TEM and bla SHV genes were identified by sequencing (Macrogen, Amsterdam, The Netherlands) using the same primers, while bla CTX-M genes were identified by the sequencing of primers of group-specific PCRs [18] . Sequence alignment and analyses were performed using CLC DNA Workbench v4.0 (CLC Bio, Aarhus, Denmark).
Aminoglycoside Resistance Genes and Characterization of Integrons
The aminoglycoside resistance genes aac(3')-
, armA , rmtA and rmtB were sought for as previously described [19] [20] [21] [22] . The detection of class 1 and class 2 integrons was performed by PCR assays according to Mazel et al. [23] and the amplification and sequencing of the variable regions were performed as described by White et al. [24] , using newly designed internal primers when necessary. Sequences were assembled in the CLC DNA Workbench 4.0 (CLC Bio), and gene cassettes were identified using the GenBank (http://www.ncbi.nlm.nih.gov). Identification of class 1 and class 2 integrons with variable regions of the same size was performed by restriction analysis using at least two enzymes for each cassette array, including Eco RI, Hind III, Mse I and Rsa I (Fermentas).
Phylogenetic Analysis of E. coli and Virulence Genes
Phylogenetic groups of E. coli were determined using the multiplex PCR method developed by Clermont et al. [25] . Phylogroups A and B1 are considered commensal, while groups B2 and D include strains responsible for extra-intestinal infections [25] . The pandemic O25b-ST131 clone was screened in the isolates of the phylogenetic group B2 with a PCR-based assay [26] .
A multiplex PCR assay was used to determine the presence of virulence factor genes characteristic for enterovirulent E. coli pathotypes, as described previously [27] .
We used PCR with previously described primers to search for genes coding for the putative extra-intestinal virulence factors of E. coli , including adhesins ( papC , fimH , sfaS and sfa/focDE ), toxins ( cnf1 and cvaC ), factors related to iron acquisition ( iutA and fyuA ), the capsule system ( kpsMT II ) and miscellaneous factors ( ibeA , PAI, traT and csgA ) [28] .
Statistical Analysis
Prevalences were compared by means of the χ 2 test or the Fisher exact test as appropriate. Age distribution in the different groups was compared by means of the Kolmogorov-Smirnov test. The distribution of genes coding for ESBLs, aminoglycosidemodifying enzyme genes and co-resistance patterns were all analyzed by χ 2 test, and the pairwise comparisons derived were adjusted with the Bonferroni correction. The association of genes with each other or with different characteristics was analyzed using the Pearson correlation. PAST v3.0 was used to perform the statistical tests [29] .
Results
Epidemiology of ESBL Producers
The overall prevalence of ESBL carriers was 3.7% (60/1,640). The LTC facility applicants carried ESBL producers (7.2%; 38/531) significantly more frequently (p < 0.001) than the individuals on employment screening (2.0%; 22/1,109). The risk of carriage of ESBL producers was not affected by the region where patients lived, by their gender or by their age in any of the comparisons.
Of the 63 ESBL-producing isolates from the 60 patients, 43 E. coli , 18 K. pneumoniae , 1 Klebsiella oxytoca and 1 Proteus mirabilis were identified. Three individuals harboured multiple ESBL-producing isolates simultaneously ( K. pneumoniae and E. coli in 2 individuals and K. oxytoca and E. coli in 1 individual, all from the LTC applicant group). Among the individuals on employment screening, only E. coli isolates could be found, but the proportion of E. coli and K. pneumoniae isolates was similar (21/41 vs. 18/41) in the LTC facility applicants.
Out of the 63 ESBL-positive isolates, 50 harboured a bla CTX-M gene; the majority of these were E. coli (38/50). The distribution of ESBL genes in the 2 groups is shown in figure 1 . All isolates carrying bla CTX-M other than bla CTX-M-15 were E. coli ; 1 E. coli isolate harboured bla CTX-M-15 and bla CTX-M-2 simultaneously. All K. pneumoniae and 5 E. coli isolates (11.6%) carried bla ; in the case of K. pneumoniae , 11 isolates harboured bla CTX-M-15 and bla SHV-12 at the same time. The distribution of the ESBL genes was significantly different (p = 0.001) between the 2 study groups; bla CTX-M-15 was more frequent in the LTC applicants (p < 0.001), and the frequencies of other genes were comparable. When comparing ESBL gene distribution among K. pneumoniae (all from the LTC applicants), E. coli from the LTC applicants and E. coli from the people on employment screening, a significant difference was found (p < 0.001). All 3 isolate groups showed significantly different distributions in pairwise comparisons (p < 0.001 to p = 0.026), mostly due to the different distribution of bla CTX-M-15 . In addition, K. pneumoniae carried bla SHV-12 more frequently than E. coli among the LTC applicants and in the employment screening group (p < 0.001).
Genetic Diversity
The genetic diversity among E. coli isolates was high on both ERIC-PCR (data not shown) and PFGE ( fig. 2 
Resistance Patterns and Aminoglycoside Resistance Genes
All ESBL-producing isolates were susceptible to colistin; carbapenem nonsusceptibility (Hodge test: negative) was detected in a single K. pneumoniae isolate harbouring bla SHV-12 . The K. pneumoniae clone detected was resistant to all the drugs tested, except for carbapenem and colistin, and it carried the aac(6')-Ib gene but no other tested aminoglycoside resistance genes.
As shown in figure 4 , resistance rates significantly differed between E. coli isolates from individuals on employment screening and on screening for LTC admission in the case of ciprofloxacin, amikacin, tobramycin and trimethoprim-sulfamethoxazole (p = 0.048 to p < 0.002). When comparing commensal vs. pathogenic E. coli isolates as classified by phylogroups, the resistance pattern was similar; however, the significant differences in ciprofloxacin and trimethoprim-sulfamethoxazole disappeared. In contrast to the K. pneumoniae clone, isolates showing resistance to all non-beta-lactam antibiotic groups (except colistin) were not found in either E. coli group.
In the E. coli isolates, the presence of the bla CTX-M-15 gene correlated positively with ciprofloxacin, amikacin and tobramycin resistance ( table 1 ). The gene bla CTX-M-1 , on the contrary, correlated negatively with resistance to amikacin and tobramycin.
The prevalences of aminoglycoside resistance genes are shown in figure 5 ; all isolates were negative for ant(2')-Ia , armA , rmtA and rmtB genes. In the case of E. coli from the LTC applicants, aminoglycoside resistance genes were distributed unevenly (p = 0.017) with more frequent 
Integrons
The K. pneumoniae clone carried a class 1 integron with a single ant(3')-1b gene, which was also found in 2 of the 3 independent isolates. In E. coli , integron carriage correlated negatively with bla CTX-M-15 ( table 1 ). The carriage rate of class 1 integrons was significantly higher in the E. coli from the employment screening group than from the LTC applicants (68.2%, 15/22 vs. 28.6%, 6/21; p = 0.01). Class 2 integrons were found in 6.3% (4/63) of the isolates (3 among the LTC facility applicants and 1 in an individual for employment screening); of these, 2 E. coli isolates harboured both integron types (1 isolate was from the LTC applicant group and the other from the employment screening group).
Seven and 2 different gene cassette arrays were identified amongst the class 1 and 2 integrons, respectively ( fig. 6 ). These arrays did not show any association with the ESBL gene carried or the study group of origin. Fig. 4 . Resistance rates in ESBL-producing isolates obtained from long-term care facility applicants and individuals on employment screening. amik = Amikacin; cip = ciprofloxacin; dox = doxycycline; gen = gentamicin; tig = tigecycline; tmp + smx = trimethoprim-sulfamethoxazole (co-trimoxazole); tob = tobramycin. * p < 0.05; * * p < 0.01; * * * p < 0.001. n.s. = Not significant. Bold text represents negative correlations. * p < 0.05; ** p < 0.01; *** p < 0.001. 
ESBL Carriage in Asymptomatic Individuals
Phylogrouping of E. coli and Analysis of Virulence Genes
Phylogenetic group analysis showed that group A covered 46.5% of strains, followed by groups B2 (25.6%), B1 (23.3%) and D (4.6%). The commensal E. coli phylogroup A was more frequent in the employment screening group (14/22 vs. 6/21; p = 0.02), but phylogroup B2 was more frequent in the LTC applicants (9/21 vs. 2/22; p = 0.01). All phylogroup B2 isolates belonged to the bla CTX-M-15 producer O25b:ST131 pandemic clone.
None of the isolates belonged to the entero-virulent pathogroups for which tests were conducted. The frequency of the examined extra-intestinal virulence factor according to phylogroup is shown in table 2 . Isolates belonging to pathogenic phylogroups showed a higher prevalence of the genes kpsMT II (p = 0.002) and fyuA (p < 0.001) than those from commensal phylogroups. The genes sfaS , cnf1 , ibeA , sfa/focDE and PAI were completely absent from the commensal isolates. The comparison E. coli isolates according to source population yielded similar results, but only the prevalence of PAI was significantly different (p = 0.017). Virulence factor patterns were not linked to the type of ESBL gene carried.
Discussion
Asymptomatic carriage of ESBL-producing Enterobacteriaceae was documented as early as 1989 in hospital patients [30] , and reports of carriage in healthy individuals soon followed [31, 32] . It became obvious that different geographical regions show different carriage rates in communities, ranging from 0.6 to 11.6% in Europe [6] , with the highest prevalence being reported in LTC applicants from Belgium. Much higher rates have been found in other regions, e.g. 63.3% in Egypt [33] and 69.3% in Thailand [34] . This geographical difference is underlined by studies reporting international travel as a risk factor for the carriage of ESBL producers [8, 35, 36] . Faecal carriage rates seem to be increasing [6, 37, 38] .
The prevalence rate found in this study among healthy individuals (those screened for employment purposes) is comparable or somewhat lower than rates reported by European studies [39, 40] . In contrast, the LTC applicants showed much higher prevalence, closer to that seen in hospitalized patients who were free of ESBL-related infections [41] a few years earlier and also that found in a contemporary study from Belgium targeting a similar patient group [42] .
The distribution of the ESBL genes in the 2 study populations differed. In the K. pneumoniae and E. coli from the LTC applicants, it was similar to that in a European study on ESBL producers from human clinical samples [43] , while higher gene diversity was found in the E. coli from the employment screening group.
Co-resistance patterns showed similarities with previous findings, e.g. the association of bla CTX-M genes with ciprofloxacin and amikacin resistance [44, 45] . Co-resistance, as expected, was highest in K. pneumoniae [45] , with a single, multi-resistant clone being dominant among the isolates. The co-resistance pattern of the 2 E. coli types was also very different. Resistance to ciprofloxacin, amikacin and tobramycin was significantly more prevalent in the LTC applicants, with the amikacin and tobramycin resistance being caused mainly by carriage of the aac(6')-Ib gene linked to bla CTX-M-15 carriage. In agreement, it was also shown that ciprofloxacin resistance is associated with aminoglycoside resistance in ES-BL-producer and non-ESBL producer E. coli [46] .
In contrast, ESBL producers from the employment screening individuals were characterized by lower co-resistance rates, a low frequency of aac(6')-Ib and a high prevalence of ant(3')-Ia , a gene which is frequently present in the intestinal E. coli of healthy individuals [47] . This difference can be attributed to the high frequency of the ST131 carrying bla CTX-M-15 in the LTC applicant group, while bla CTX-M-1 carrier isolates, regardless of origin, were characterized by their low rate of co-resistance to other antibiotic classes and their lack of the aac(6')-Ib gene. In addition, several virulence factors were more frequently found in the isolates from LTC applicants, also attributable to the higher frequency of ST131 in this group. The differences in the distribution of the carried ESBL genes and other characteristics between the 2 populations in this study may be explained, in our opinion, by the different probable source of colonization. Most carriers in the group being screened for work eligibility presumably represent acquisition events independent of hospitals (rather community-related) whereas the group of LTC applicants probably represents mainly nosocomial acquisition. This serves as an explanation for the observations that K. pneumoniae , a typical nosocomial pathogen, was absent in the employment screening group, and that the E. coli isolates from the LTC applicants were more similar to K. pneumoniae than to E. coli isolates from the employment screening group with regard to a number of characteristics, including (1) a significantly lower diversity of the bla CTX-M genes, (2) a significantly higher frequency of bla CTX-M-15 and (3) the occurrence of aminoglycoside resistance genes aac(6')-Ib and ant(3')-Ia . This assumption is further supported by the lower occurrence of the commensal phylogroup A and the higher occurrence of the pathogenic phylogroup B2 in the E. coli from the LTC applicants and the frequent isolation of the pandemic ST131 clone from this group as well as by differences in the co-resistance patterns. Interestingly, these characteristics of E. coli were better explained by origin (i.e. LTC applicants vs. employment screening) than by phylogrouping (i.e. commensal vs. pathogenic).
These data, taken together, suggest that ESBL carriage in the community (employment eligibility group) is characterized by different colonization sources. The most obvious source is the exportation of hospital-derived strains either by colonized patients who have been discharged or by hospital workers; such events may be responsible for the introduction of the pathogenic ST131 clone carrying bla CTX-M-15 which causes significant morbidity both in hospitals and in the community setting [48] . The source for colonization with isolates carrying bla SHV may be horizontal gene transfer from exported K. pneumoniae isolates [49] [50] [51] , while various potential environmental sources should also be considered for bla CTX-M genes other than bla CTX-M-15 , including food [52, 53] , companion animals [54, 55] , wild animals [56, 57] surface water [58] , drinking water [59] and food [52] , either through direct transfer of the resistant bacteria or by the horizontal spread of resistance plasmids to human commensal E. coli . This assumption is supported by the dominance of bla CTX-M-1 among isolates from the work eligibility group and the parallel dominance of bla CTX-M-1 in animal-derived Hungarian ESBL-producing E. coli isolates [53] , in a Polish sample set from water birds [57] and in samples from food and food animals in Switzerland [52] as well as by the high frequency of bla CTX-M-2 and bla CTX-M-32 in samples originating in food animals [53, 60] . These bla genotypes were found exclusively in the individuals screened for work eligibility purposes in this study. The relatedness of animal and human isolates has also been demonstrated in some studies, pointing to a possible zoonotic spread of ESBL-producing E. coli [56, 61] .
The presented data underline the complex epidemiology of ESBL producers in the community setting. The ESBL producers or ESBL-encoding genes may reach the human gut microbiota in the community setting via two main routes. Colonization may be the result of the exportation of nosocomial K. pneumoniae or E. coli , characterized by a dominance of bla CTX-M-15 , multiple co-resistance to other drug types and frequently by clonal spread. The other starting point may be the different environmental sources of mainly commensal E. coli characterized by diverse ESBL genes and a high diversity of genotypes of carrier bacteria as well as by a low rate of co-resistance. Though the extent of contribution to human infection by the latter group has still to be established, the increasing prevalence demonstrated by several authors [6 , 62] is definitely cause for alarm.
